Shukra Pharmaceuticals News

Shukra Pharma closes trading window for Q2FY27

Shukra Pharmaceuticals Ltd closes its trading window from October 1, 2026, for Q2FY27 results. Insiders barred from trading until 48 hours post-declaration.

Shukra Pharma issues corrigendum for name change to Medtech

Shukra Pharmaceuticals Ltd issued a corrigendum to its postal ballot notice regarding the name change to Shukra Medtech Limited. The update replaces the auditor's certificate with revised numerical parameters required by BSE.

Shukra Pharmaceuticals approves preferential issue

Shukra Pharmaceuticals approved the preferential issue of 46,43,000 convertible equity warrants to promoters. The resolution was passed during the EOGM held on July 06, 2026.

Shukra Pharmaceuticals appoints new Company Secretary

Shukra Pharmaceuticals appointed Shivkant Dhakad as Company Secretary effective June 15, 2026. Arpita Kabra resigned from the post on the same date.

Shukra Pharmaceuticals to ratify EGM resolution

Shukra Pharmaceuticals Ltd. will hold a board meeting on June 10, 2026, to ratify a member's resolution passed in the EGM dated November 1, 2025.